• About The Series
• Vol.1
• Vol.2
• Vol.3

As a physician scientist, Dr. Ley has been devoted to both the treatment and the basic research of acute myeloid leukemia (AML) since 1980’s. In this interview, Dr. Ley will talk about the significance of the recent results from the first whole-genome sequencing of an AML patient, which was a landmark discovery in the field of cancer genomics. Dr. Ley will also tell us about the next strategies for cancer research, the impact of the whole-genome sequencing technology on personalized medicine, and a continuous challenge to promote translational research.

Download Video Clips

The Significance of the Whole-genome Sequencing of an AML Patient

• [Nov 17th, 2009]

QuickTime・iTunes	m4v 68.4MB
Windows Media Player	wmv 106MB

Seeking for the Holy Grail of Cancer Genome

• [Nov 24th, 2009]

QuickTime・iTunes	m4v 68.1MB
Windows Media Player	wmv 106MB

The Dawn of a New Era in Cancer Genomics and the Cost of Genome Sequencing

• [Dec 1th, 2009]

QuickTime・iTunes	m4v 48.7MB
Windows Media Player	wmv 75.6MB

The Next Powerful Strategies for Cancer Research

• [Dec 1th, 2009]

QuickTime・iTunes	m4v 61.7MB
Windows Media Player	wmv 95.9MB

The Impact of the Whole-genome Sequencing Technology on Personalized Medicine and Society

• [Dec 8th, 2009]

QuickTime・iTunes	m4v 58.9MB
Windows Media Player	wmv 91.6MB

A Daunting Challenge: Promoting Translational Research

• [Dec 8th, 2009]

QuickTime・iTunes	m4v 50.5MB
Windows Media Player	wmv 78.1MB